Explore the full management transaction log of Entero Therapeutics, Inc., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 8 January 2025 (Cession). Among the most active insiders: Romano Sarah. Every trade is accessible without an account.
5
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€2,547
4 ops.
Sell Volume
42Σ signal
Buys ·€2,547 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.